Brief: Astellas Pharma Inc - Padcev And Keytruda Significantly Improve Overall Survival And Progression-Free Survival In Patients With Previously Untreated Advanced Bladder Cancer
22/09/2023 10:01
Sept 22 (Reuters) - Astellas Pharma Inc 4503.T :
* ASTELLAS PHARMA INC: PADCEV AND KEYTRUDA SIGNIFICANTLY
IMPROVE
OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH
PREVIOUSLY UNTREATED ADVANCED BLADDER CANCER
Source text for Eikon: ID:nTSuv88167
Further company coverage: 4503.T
(Reporting by Tokyo Newsroom)
((+81345201189;))